Johnson & Johnson (JNJ) News Headlines

▮ More

Date

Headline

6/11/2021 6:26:32 PM FDA Asks J&J To Discard About 60 Mln Covid Vaccine Doses Due To Potential Contamination

6/7/2021 1:43:19 AM Argenx To Regain Global Rights To Anti-CD70 Antibody Cusatuzumab From Janssen's Cilag

6/1/2021 4:41:40 PM Supreme Court Dismisses J&J Appeal Against The $2bln Fine

5/28/2021 9:00:13 AM Johnson & Johnson's Single Dose COVID-19 Vaccine Approved In U.K.

5/21/2021 10:29:21 AM Janssen Gets Two Positive CHMP Opinions For Darzalex Subcutaneous Formulation Utilizing Enhanze

5/21/2021 10:15:31 AM Halozyme : Janssen Gets Two Positive CHMP Opinions For DARZALEX Subcutaneous Formulation Utilizing ENHANZE

5/3/2021 7:06:06 AM Eupraxia Pharma Appoints Bruce Cousins As President & CFO

4/26/2021 8:38:14 AM J&J Vaccine Holds Lower Side Effect Risks Than Aspirin: NIH Director

4/26/2021 12:26:26 AM FDA Lifts Pause On Johnson & Johnson's COVID-19 Vaccine

4/23/2021 7:49:14 PM Johnson & Johnson Single-Shot COVID-19 Vaccinations To Resume In US For Adults Aged 18 And Above

4/20/2021 2:00:03 PM EMA Says J&J Covid Vaccine's Benefits Outweigh Rare Blood Clot Risks

4/20/2021 11:56:43 AM Johnson & Johnson COVID-19 Vaccine Roll-out To Resume In Europe Following European Medicines Agency Review

4/20/2021 7:43:16 AM Johnson & Johnson Q1 Results Top Estimates

4/20/2021 6:47:59 AM Johnson & Johnson (JNJ) Declares Quarterly Dividend of $ 1.06, Record Date 5/25/2021

4/20/2021 6:44:52 AM Johnson & Johnson Declares 5.0% Increase In Quarterly Dividend To $1.06, Payable June 8, Record May 25

4/20/2021 6:35:10 AM Johnson & Johnson Q1 adjusted earnings Beat Estimates

4/20/2021 6:32:30 AM Johnson & Johnson Q1 EPS $2.32; Adj EPS $2.59

4/20/2021 6:01:45 AM Johnson & Johnson Q1 21 Earnings Conference Call At 8:30 AM ET

4/19/2021 9:08:56 AM Decision On Resuming Johnson & Johnson Vaccine Expected This Week

4/14/2021 5:10:49 PM EMA Says Johnson & Johnson's COVID-19 Vaccine's Benefits Outweigh Side Effects